Results of Prolonged Treatment with Pentolinium Tartrate
- 1 June 1956
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 13 (6) , 856-865
- https://doi.org/10.1161/01.cir.13.6.856
Abstract
A series of 96 patients with severe hypertension has been treated with pentolinium tartrate for an average period of 12 months. Seventeen patients died. Therapy was more effective in arresting changes in the optic fundi and in the heart than in the kidneys. Various combinations of hypotensive agents were tested and it was concluded that in general the combination of pentolinium tartrate, Rauwolfia and hydralazine resulted in the greatest reduction of blood pressure with the least degree of side effects due to ganglionic "blockade."Keywords
This publication has 12 references indexed in Scilit:
- TREATMENT FOR HYPERTENSIONJAMA, 1955
- The Use of Pentolinium Tartrate with and without Hydralazine in the Treatment of Severe HypertensionNew England Journal of Medicine, 1955
- The Treatment of Essential Hypertension with Pentolinium Tartrate Combined with Rauwolfia AlkaloidsBMJ, 1955
- Mental Depression in Hypertensive Patients Treated for Long Periods with Large Doses of ReserpineNew England Journal of Medicine, 1954
- CONTROL OF BLOOD-PRESSURE BY COMBINED ACTION OF RESERPINE AND PENTAPYRROLIDINIUMThe Lancet, 1954
- THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. III. HEXAMETHONIUM 123Journal of Clinical Investigation, 1953
- Parenteral Hexamethonium in HypertensionBMJ, 1953
- ACTION OF A NEW METHONIUM COMPOUND IN ARTERIAL HYPERTENSION PENTAMETHYLENE 1 : 5-BIS-N- (N-METHYL-PYRROLIDINIUM) BITARTRATE (M. & B. 2050A)The Lancet, 1953
- PHARMACOLOGY OF M. & B. 2050The Lancet, 1953
- 430. Some bisquaternary saltsJournal of the Chemical Society, 1952